 |
||
|
How to Obtain AMA PRA Category 1 Credit™
|
|
 |
||
Volume 78, Number 7
Bronchial thermoplasty:
A new treatment for severe refractory asthma
First Step: Review Information Below to Begin Activity
Release Date: July 1, 2011
Expiration Date: June 30, 2012
Description
Each learning activity within the Cleveland Clinic Journal of Medicine CME series is based on an article from the Cleveland Clinic Journal of Medicine, a post-test, and an evaluation.
Learning Objective
Readers will describe the indications for bronchial thermoplasty.
Target Audience
Directed to internists, and other physicians.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity DirectorBrian F. Mandell, MD, PhDChairman, Department of Medicine, Education Institute Professor of Medicine, Cleveland Clinic Lerner College of Medicine Editor-in-Chief, Cleveland Clinic Journal of Medicine Cleveland Clinic Cleveland, OH |
Co-Activity DirectorTimothy Gilligan, MDTaussig Cancer Institute and Department of Bioethics Deputy Editor, Cleveland Clinic Journal of Medicine Cleveland Clinic Cleveland, OH |
Authors / Faculty
| Thomas R. Gildea, MD, MS Respiratory Institute, Cleveland Clinic; Site Co-investigator, AIR2 trial of bronchial thermoplasty Cleveland, OH |
Sumita B. Khatri, MD, MS Respiratory Institute, Cleveland Clinic, Cleveland, OH |
Mario Castro, MD, MPH Professor of Medicine and Pediatrics, Division of Pulmonary & Critical Care Medicine, Washington University School of Medicine, St. Louis, MO; Principal Investigator AIR2 trial of bronchial thermoplasty |
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
| Brian F. Mandell, MD, PhD (Activity Director) | ||
| Fees for consulting and speaking (CME lectures): | Takeda Pharmaceuticals |
|
| Paid independent contractor (clinical trials): | Savient Pharmaceuticals | |
| Consultant: | URL Pharma | |
| Section editor (rheumatology and immunology): | The Merck Manual | |
| Thomas R. Gildea, MD, MS | |||
| Funded research (AIR2 trial): | Asthmatx | ||
| Mario Castro, MD, MPH | |||
| Funded research (AIR2 trial): | Asthmatx | ||
The following faculty have indicated they have no relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
Timothy Gilligan, MD (Co-Activity Director)
Sumita B. Khatri, MD, MS
All other CCJM staff report no relevant financial relationships.
Next Step:
This activity has expired. You may read the article without CME credit on the CCJM site.
(Article opens in new tab / window; return to this window to complete the activity).
This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.
